Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 1Medichem, S.A. Sant Joan Despí ES
02 2AESICA PHARMACEUTICALS LIMITED Cramlington GB
03 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
04 1CHEMI S.P.A. Patrica IT
05 1GEDEON RICHTER PLC Budapest HU
06 1IPCA Laboratories Limited Mumbai IN
07 1JUBILANT PHARMOVA LIMITED Nanjangud IN
08 2TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
09 1Wanbury Limited Vashi, Navi Mumbai IN
10 2ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
11 1ZYDUS LIFESCIENCES LIMITED Vadodara IN
12 1Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City CN
01 3Paroxetine hydrochloride
02 12Paroxetine hydrochloride hemihydrate
01 3China
02 1Hungary
03 7India
04 1Italy
05 1Spain
06 2United Kingdom
01 1Expired
02 12Valid
03 2Withdrawn by Holder
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2011-200 - Rev 00
Status : Valid
Issue Date : 2018-03-05
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2011-188 - Rev 02
Status : Valid
Issue Date : 2020-06-19
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2003-250 - Rev 02
Status : Valid
Issue Date : 2022-07-28
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2014-095 - Rev 00
Status : Valid
Issue Date : 2021-01-11
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2009-204 - Rev 02
Status : Valid
Issue Date : 2022-08-23
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : CEP 2009-154 - Rev 03
Status : Valid
Issue Date : 2024-07-19
Type : Chemical
Substance Number : 2018
Certificate Number : CEP 2009-155 - Rev 04
Status : Valid
Issue Date : 2024-07-19
Type : Chemical
Substance Number : 2283
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2012-376 - Rev 00
Status : Valid
Issue Date : 2019-03-08
Type : Chemical
Substance Number : 2018
Paroxetine Hydrochloride Hemihydrate
Certificate Number : R1-CEP 2006-192 - Rev 01
Status : Valid
Issue Date : 2017-06-27
Type : Chemical
Substance Number : 2018
Certificate Number : R1-CEP 2006-002 - Rev 01
Status : Valid
Issue Date : 2014-01-06
Type : Chemical
Substance Number : 2283
A Paroxetine Hydrochloride Hemihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paroxetine Hydrochloride Hemihydrate, including repackagers and relabelers. The FDA regulates Paroxetine Hydrochloride Hemihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paroxetine Hydrochloride Hemihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Paroxetine Hydrochloride Hemihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Paroxetine Hydrochloride Hemihydrate supplier is an individual or a company that provides Paroxetine Hydrochloride Hemihydrate active pharmaceutical ingredient (API) or Paroxetine Hydrochloride Hemihydrate finished formulations upon request. The Paroxetine Hydrochloride Hemihydrate suppliers may include Paroxetine Hydrochloride Hemihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Paroxetine Hydrochloride Hemihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Paroxetine Hydrochloride Hemihydrate CEP of the European Pharmacopoeia monograph is often referred to as a Paroxetine Hydrochloride Hemihydrate Certificate of Suitability (COS). The purpose of a Paroxetine Hydrochloride Hemihydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Paroxetine Hydrochloride Hemihydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Paroxetine Hydrochloride Hemihydrate to their clients by showing that a Paroxetine Hydrochloride Hemihydrate CEP has been issued for it. The manufacturer submits a Paroxetine Hydrochloride Hemihydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Paroxetine Hydrochloride Hemihydrate CEP holder for the record. Additionally, the data presented in the Paroxetine Hydrochloride Hemihydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Paroxetine Hydrochloride Hemihydrate DMF.
A Paroxetine Hydrochloride Hemihydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Paroxetine Hydrochloride Hemihydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Paroxetine Hydrochloride Hemihydrate suppliers with CEP (COS) on PharmaCompass.
We have 12 companies offering Paroxetine Hydrochloride Hemihydrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
